National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Hepatology. 2011 May;53(5):1600-7. doi: 10.1002/hep.24173.
Some patients with liver disease progress to cirrhosis, but the risk factors for cirrhosis development are unknown. Dyskeratosis congenita, an inherited bone marrow failure syndrome associated with mucocutaneous anomalies, pulmonary fibrosis, and cirrhosis, is caused by germline mutations of genes in the telomerase complex. We examined whether telomerase mutations also occurred in sporadic cirrhosis. In all, 134 patients with cirrhosis of common etiologies treated at the Liver Research Institute, University of Arizona, between May 2008 and July 2009, and 528 healthy subjects were screened for variation in the TERT and TERC genes by direct sequencing; an additional 1,472 controls were examined for the most common genetic variation observed in patients. Telomere length of leukocytes was measured by quantitative polymerase chain reaction. Functional effects of genetic changes were assessed by transfection of mutation-containing vectors into telomerase-deficient cell lines, and telomerase activity was measured in cell lysates. Nine of the 134 patients with cirrhosis (7%) carried a missense variant in TERT, resulting in a cumulative carrier frequency significantly higher than in controls (P = 0.0009). One patient was homozygous and eight were heterozygous. The allele frequency for the most common missense TERT variant was significantly higher in patients with cirrhosis (2.6%) than in 2,000 controls (0.7%; P = 0.0011). One additional patient carried a TERC mutation. The mean telomere length of leukocytes in patients with cirrhosis, including six mutant cases, was shorter than in age-matched controls (P = 0.0004).
Most TERT gene variants reduced telomerase enzymatic activity in vitro. Loss-of-function telomerase gene variants associated with short telomeres are risk factors for sporadic cirrhosis.
一些肝病患者会发展为肝硬化,但肝硬化发展的危险因素尚不清楚。先天性角化不良是一种与黏膜皮肤异常、肺纤维化和肝硬化相关的遗传性骨髓衰竭综合征,由端粒酶复合物中的基因突变引起。我们研究了散发性肝硬化中是否也存在端粒酶突变。总共对 2008 年 5 月至 2009 年 7 月在亚利桑那大学肝脏研究所接受治疗的 134 名常见病因肝硬化患者和 528 名健康受试者进行了端粒酶 TERT 和 TERC 基因的直接测序,以筛选是否存在变异;另外还检查了 1472 名对照者中患者最常见的遗传变异。通过定量聚合酶链反应测量白细胞端粒长度。通过将含突变的载体转染到端粒酶缺陷细胞系中,评估遗传变化的功能效应,并在细胞裂解物中测量端粒酶活性。在 134 名肝硬化患者中,有 9 名(7%)患者携带 TERT 错义变异,导致携带者频率明显高于对照组(P = 0.0009)。其中 1 名患者为纯合子,8 名患者为杂合子。肝硬化患者最常见的 TERT 错义变异等位基因频率明显高于 2000 名对照者(2.6%比 0.7%;P = 0.0011)。另外一名患者携带 TERC 突变。包括 6 例突变病例在内的肝硬化患者白细胞端粒长度均短于年龄匹配的对照组(P = 0.0004)。
大多数 TERT 基因突变体外降低端粒酶酶活性。与短端粒相关的失能端粒酶基因突变是散发性肝硬化的危险因素。